Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Av. de los Shyris Km. 5 12, Icio Bldg.
Sangolqui; Pichincha; Map
Tel: +593-2-382-, +593-2-382-
Email: @corporaciongpf.com, email@example.com
Full name: Provefarma S.A.
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 07-May-90
Provefarma S.A aims social import, export and distribution of products to pharmacies, clinics and hospitals as well as to stores and supermarkets.
EMIS Benchmark Score
Import connections ('000)
China (2.39 USD)
Germany (511 USD) (57.24 %)
Brazil (76.44 USD) (8.56 %)
United States (6.64 USD)
Austria (10.61 USD) (1.19 %)
Chile (284.98 USD) (31.92 %)
|Net sales revenue|
|Total operating revenue|
|Operating profit (EBIT)|
|Net Profit (Loss) for the Period|
|Operating Profit (EBIT) Margin|
|Return on Sales (ROS)|
|Return on Equity (ROE)|
|Debt to Equity|
|Company Tear Sheet|
|NAICS Industry Classification||✓||✕|
|Share Price information||✓||✕|
|Subsidiaries and Affiliates||✓||✕|
|Key Financial Highlights||✓||✕|
|Financial Performance Charts||✓||✕|
|Latest M&A and ECM Deals||✓||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✓||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.